Suppr超能文献

微量白蛋白尿与动脉粥样硬化性心血管疾病:糖尿病肾病患者的过渡研究。

Low-grade proteinuria and atherosclerotic cardiovascular disease: A transition study of patients with diabetic kidney disease.

机构信息

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Department of Internal Medicine, Japan Community Health Care Organization Osaka Hospital, Osaka, Osaka, Japan.

出版信息

PLoS One. 2022 Feb 25;17(2):e0264568. doi: 10.1371/journal.pone.0264568. eCollection 2022.

Abstract

Diabetic kidney disease (DKD) is heterogeneous in terms of proteinuria. Patients with DKD who present with low-grade proteinuria are more likely to have nephrosclerosis rather than traditional diabetic nephropathy. The amount of proteinuria might reflect the underlying pathology of renal failure and influence the prognosis after dialysis initiation. Clinical implications of proteinuria at the start of dialysis have not been confirmed, while greater proteinuria is associated with higher risk of cardiovascular disease (CVD) in the predialysis stages of chronic kidney disease. We performed a retrospective multicenter cohort study enrolling incident hemodialysis patients with diabetes. Patients were stratified using proteinuria quartiles. We examined the association of proteinuria quartiles with types of subsequent CVD. Among the enrolled 361 patients, the estimated mean glomerular filtration rate and proteinuria was 5.4 mL/min/1.73 m2 and 6.3 g/gCr, respectively. Lower quartile of proteinuria (cut-offs: 3.0, 5.4, and 8.8 g/gCr) was significantly associated with male, older age, and history of atherosclerotic CVD including coronary artery disease, peripheral arterial disease, and cerebral infarction (Ptrend<0.05). Kidney size was smaller in patients with lower levels of proteinuria. Patients with higher levels of proteinuria were more likely to have proliferative diabetic retinopathy (Ptrend<0.05). Multivariate competing risk analysis revealed that the first quartile of proteinuria was associated with a greater risk of atherosclerotic CVD than the third quartile (subhazard ratio [95% confidence interval]: 2.04 [1.00-4.14]). This association was attenuated after additional adjustments for history of atherosclerotic CVD. Furthermore, patients with lower quartiles of proteinuria were more likely to die of atherosclerotic CVD than those with non-atherosclerotic CVD (Ptrend = 0.01). Diabetic patients with lower proteinuria at dialysis initiation were characterized by severer macroangiopathy, as shown by a more atrophic kidney and higher prevalence of past atherosclerotic CVD. Hence, they are at a high risk of developing atherosclerotic CVD.

摘要

糖尿病肾病(DKD)在蛋白尿方面存在异质性。表现为低水平蛋白尿的 DKD 患者更可能发生肾硬化而非传统的糖尿病肾病。蛋白尿的量可能反映了肾衰竭的潜在病理,并影响透析开始后的预后。透析开始时蛋白尿的临床意义尚未得到证实,而在慢性肾脏病的透析前阶段,更大的蛋白尿与更高的心血管疾病(CVD)风险相关。我们进行了一项回顾性多中心队列研究,纳入了新诊断的糖尿病血液透析患者。患者根据蛋白尿四分位进行分层。我们研究了蛋白尿四分位与随后 CVD 类型的关系。在纳入的 361 名患者中,估算的平均肾小球滤过率和蛋白尿分别为 5.4 mL/min/1.73 m2 和 6.3 g/gCr。蛋白尿四分位的较低分位(截取值:3.0、5.4 和 8.8 g/gCr)与男性、年龄较大以及存在动脉粥样硬化性 CVD 病史(包括冠心病、外周动脉疾病和脑梗死)显著相关(Ptrend<0.05)。蛋白尿水平较低的患者肾脏较小。蛋白尿水平较高的患者更可能患有增生性糖尿病视网膜病变(Ptrend<0.05)。多变量竞争风险分析显示,与第三四分位相比,第一四分位的蛋白尿与动脉粥样硬化性 CVD 的风险更高(亚危险比[95%置信区间]:2.04[1.00-4.14])。在对动脉粥样硬化性 CVD 病史进行额外调整后,这种关联减弱。此外,与非动脉粥样硬化性 CVD 相比,蛋白尿较低四分位的患者死于动脉粥样硬化性 CVD 的可能性更大(Ptrend=0.01)。在透析开始时蛋白尿较低的糖尿病患者表现出更严重的大血管病变,表现为肾脏更萎缩,过去动脉粥样硬化性 CVD 的患病率更高。因此,他们患动脉粥样硬化性 CVD 的风险很高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa33/8880428/b194aa25c16e/pone.0264568.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验